GcMAF Immunotherapy: Immune system dysfunction is well known in Autism. GcMAF treatment is a highly effective macrophage activating therapy, used to stimulate the immune system and activate macrophages, which are present in all tissues of our body.
 
Macrophage migration inhibitory factor (MIF): One cytokine associated with autism is called macrophage migration inhibitory factor (MIF). MIF is an immune regulator that promotes inflammation and is consistently present in brain tissues. It plays crucial roles in influencing both neural and endocrine systems. This cytokine is produced by tissues involved in both the nervous system and the immune system. Additionally, macrophage migration inhibitory factor acts as an antagonist to glucocorticoids in the immune system and plays a role in regulating various endocrine circuits.
 
• People with autism show elevated levels of macrophage migration inhibitory factor (MIF) in their blood.
• Those with autism who had the highest levels of MIF in their blood exhibited the most severe behavioral symptoms.
• Macrophage migration inhibitory factor plays a crucial role in the body's response to microbial infections and is involved in various autoimmune diseases.
• The expression of macrophage migration inhibitory factor is typically
constant at low levels.
 
Key benefits of GcMAF
Improves neuronal protection and production.
Increases energy at mitochondria level
Inhibits overall inflammation at cellular level